Volume 8, Issue 2 (2022)                   Pharm Biomed Res 2022, 8(2): 0-0 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Manucha W, Martín Giménez V M, Sanz R, Bonafede R, Mazzei L. Novel Possible Biomarkers for the Cardiovascular Diseases Prognosis. Pharm Biomed Res. 2022; 8 (2)
URL: http://pbr.mazums.ac.ir/article-1-445-en.html
1- Laboratorio de Farmacología Experimental, Básica y Traslacional. Área de Farmacología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina
2- Instituto de Investigaciones en Ciencias Químicas, Facultad de Ciencias Químicas y Tecnológicas, Universidad Católica de Cuyo, San Juan, Argentina
3- Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina
4- Unidad de Insuficiencia Cardíaca, Servicio de Cardiología del Hospital Central de Mendoza, Argentina
5- Instituto de Medicina y Biología Experimental de Cuyo(IMBECU), CCT-Mendoza, CONICET, Mendoza, Argentina
Abstract:   (114 Views)
Cardiovascular disease (CVD), especially heart failure (HF) as its common final pathway, is the leading cause of morbidity and mortality worldwide. Furthermore, oxidative and inflammatory processes represent fundamental underlying mechanisms for the development and progression of HF. Of interest, in recent years the development of markers with diagnostic and prognostic value for this pathology and other related CVD has been revalued. Therefore, the objective of the present study was to quantify and evaluate inflammatory markers such as ultrasensitive CRP, IL-6, TNF-α and Hsp70 in the serum of patients with heart failure (HF) and to compare them with healthy individuals, also correlating the values obtained with oxidative stress markers and nitric oxide bioavailability previously investigated in these patients, as well as with the coexistence or not of secondary pulmonary hypertension (SPH) associated with HF. The determination of these mediators was achieved with standardized, reproducible, accurate and affordable biochemical methods. The values ​​obtained for uCRP, IL-6 and TNF-α were in accordance with the pattern of oxidative markers previously found in these patients, thus exposing the coexistence of oxidative stress and inflammation during HF, but which is more exacerbated even when it is associated with SPH, which it finds would increase its value as a biomarker in this pathology. However, the found levels of Hsp70 were controversial. Therefore, additional studies are needed to assess in greater detail the importance of the relationship between serum Hsp70 expression and SPH-associated or non-SPH morbidity in HF.

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb